TY - JOUR
T1 - Adolescent Anabolic-Androgenic Steroid Use in Association With Other Drug Use, Injection Drug Use, and Team Sport Participation
AU - Schneider, Kristin E.
AU - Webb, Lindsey
AU - Boon, Denali
AU - Johnson, Renee M.
N1 - Funding Information:
KES, LW, and DB were supported by a NIDA training grant [5T32DA007292]. This work was supported by the Opioid Policy Tools and Information Center of Excellence (OPTIC) Pilot Project award, funded by grant [P50DA046351] from the National Institute on Drug Abuse. The funding organization had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.
Publisher Copyright:
© 2022 Taylor & Francis Group, LLC.
PY - 2020
Y1 - 2020
N2 - Introduction: The majority of epidemiologic research on adolescent non-medical anabolic-androgenic steroid (AAS) use was conducted in the 1990s and early 2000s, indicating a need to update evidence for the modern era. We aim to understand the prevalence of AAS use among US adolescents and assess associations between AAS use, sports participation, other drug use, and injection drug use (IDU). Methods: Using data from the 2017 National Youth Risk Behavior Survey, we estimated the prevalence of AAS use and tested for associations between AAS use, sports participation, and drug use, overall and by sex. Results: The prevalence of AAS use was 2.98%. The prevalence among boys (3.46%) was higher than among girls (2.41%). AAS use was high among youth with lifetime heroin use (64.41%) and IDU (64.42%). There was no association between AAS and team sport participation (p = 0.61). Conclusions: Our results indicate that adolescent AAS use is an aspect of polysubstance use rather than a substance used solely for performance enhancement in sports. Research with adolescents should be mindful of the overlap of heroin and AAS use among youth with IDU.
AB - Introduction: The majority of epidemiologic research on adolescent non-medical anabolic-androgenic steroid (AAS) use was conducted in the 1990s and early 2000s, indicating a need to update evidence for the modern era. We aim to understand the prevalence of AAS use among US adolescents and assess associations between AAS use, sports participation, other drug use, and injection drug use (IDU). Methods: Using data from the 2017 National Youth Risk Behavior Survey, we estimated the prevalence of AAS use and tested for associations between AAS use, sports participation, and drug use, overall and by sex. Results: The prevalence of AAS use was 2.98%. The prevalence among boys (3.46%) was higher than among girls (2.41%). AAS use was high among youth with lifetime heroin use (64.41%) and IDU (64.42%). There was no association between AAS and team sport participation (p = 0.61). Conclusions: Our results indicate that adolescent AAS use is an aspect of polysubstance use rather than a substance used solely for performance enhancement in sports. Research with adolescents should be mindful of the overlap of heroin and AAS use among youth with IDU.
KW - Adolescents
KW - Youth Risk Behavior Survey
KW - anabolic-androgenic steroids
KW - injection drug use
UR - http://www.scopus.com/inward/record.url?scp=85127175612&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85127175612&partnerID=8YFLogxK
U2 - 10.1080/1067828X.2022.2052219
DO - 10.1080/1067828X.2022.2052219
M3 - Article
AN - SCOPUS:85127175612
SN - 1067-828X
VL - 29
SP - 246
EP - 251
JO - Journal of Child and Adolescent Substance Abuse
JF - Journal of Child and Adolescent Substance Abuse
IS - 4-6
ER -